Precis: A novel mouse model provides insights into the dynamics of cellular senescence, a central mechanism for tumor suppression. 
Introduction
Cellular senescence is a coordinated program activated by cells in response to a variety of physiological stresses, including DNA damage and oncogenic signaling (1) (2) (3) . Senescent cells have been identified in early tumor lesions in mouse models and human samples (4) , providing evidence that senescence is an important barrier to cancer formation. Cells entering senescence undergo cellcycle arrest, which is thought to be irreversible, accompanied by dramatic changes in morphology, chromatin structure and metabolism (1) (2) (3) . The Rb and p53 tumor suppressor proteins are central in the execution of senescence, and are most often activated in this context by the two products of the Ink4a (1, 2, 5) . These genes are not expressed in the large majority of tissues in the embryo and the adult, but are transcriptionally activated during stress, tumorigenesis or aging (6) (7) (8) .
Senescence has been detected in vivo in various contexts, including in tissues suffering from DNA damage or shortened telomeres (9, 10) , chemotherapy-treated tumors (11, 12) , and tissues undergoing wound healing, fibrosis or inflammation (13) (14) (15) . Senescence is also detected during aging (16) (17) (18) and is thought to contribute to this process, potentially through the depletion of functional stem cells (1) (2) (3) .
Secretion of inflammatory cytokines and ECM components, an important aspect of the senescent cell phenotype, could influence tissue aging and exert other non-cell-autonomous effects, including stimulation of proliferation of neighboring cells (19) .
While senescent cells can remain viable in culture for months and years, their fate in vivo is unclear.
The detection of senescent cells in aged tissues suggests that they can accumulate and affect tissue physiology. Consistent with this, experimental removal of senescent cells prevents aging-like phenotypes caused by genetically-induced aneuploidy (20) . However, recent studies have shown that immune cells recruited through cytokine secretion rapidly clear senescent cells from cancerous or 4 fibrotic tissue (13, 21, 22) . Whether additional mechanisms act to eliminate senescent cells is not known, and a detailed analysis of the retention rates of senescent cells in tissues is lacking.
Basic study of the senescence program in vivo is essential for understanding its various physiological roles, including tumor suppression. To allow the study of senescent cells in vivo, the dynamics of their formation and removal, and their effects on adult tissues, we sought to develop a system in which senescence could be activated in a direct and controlled manner. We generated transgenic mice carrying a tetracycline-inducible p14 ARF gene, a central activator of senescence, whose product activates p53 through Mdm2 sequestration (23) . We focused on the skin as a model epithelial tissue, in which senescence is thought to occur during normal aging (16, 24) . Our findings reveal basic aspects of the dynamics of senescent cell formation and retention in the epidermis.
Materials and Methods

Transgenic mice
To generate tet-p14 mice we relied on Flp/FRT-mediated recombination into ES cells (25) . We cloned the human p14 ARF coding sequence into the pBS31 vector, which contains an FRT recombination site and a tet-responsive element, and transfected this plasmid together with a Flp/e expression vector into the KH2 ES cells, in which an FRT site was placed in the Col1a1 gene locus. Recombined cells were injected into tetraploid blastocysts for implantation. Tet-p14 mice (mixed C57Bl6 and 129sv) were crossed with K5-rtTA mice (FVB) (26) and with tet-shp53 mice (mixed C57Bl6 and 129sv) (27) . For transgene induction 2mg/ml doxycyclin (dox) was added to the drinking water of double-transgenic mice and sibling control single-transgenics at 3 weeks of age. For BrdU labeling mice were injected with 0.1mg/gr body-weight two hours prior to sacrifice. For hyperplasia induction mice were treated three times a week with 6.5μg TPA in 100ml acetone; untreated skin regions from the same mice were collected as control tissue.
Immunohistology
Upon sacrifice mice were shaved and back skins were dissected, formalin-fixed and paraffin embedded. Immunohistology was performed according to standard procedures, using Peroxidase Subtrate kits (Vector) or fluorescently labeled secondary antibodies (Jackson) . Antibodies used: p14 ARF (ab3642, Abcam), p21 (sc-6246, Santa Cruz), p53 (CM5p, Novocastra), p19
(RM-9106, Labvision), BrdU (MS-1058, Labvision), CC3 (#9661, Cell Signaling), K14 (GP-CK14, Progen), K5 (GP-CK5, Progen), and K15 (sc-56520, Santa Cruz). In Situ Cell Death Detection Kit (Roche) was used for TUNEL. Images were collected using an Olympus BH2 upright or a Nikon Eclipse Ti inverted fluorescent microscope, using DS-Qi1Mc and DS-Fi1 cameras and processed using NIS Elements software (Nikon), in some cases using the EDF function for Z-stacking. Where noted we used a Zeiss LSM710 confocal microscope.
Results
p14
ARF induction in the skin
To develop a system for the induction of senescence in the adult skin we generated p14 ARF tetracycline-inducible mice (tet-p14). We used the human gene to facilitate the distinction between endogenous p19 ARF and the transgene. Tet-p14 mice were crossed with K5-rtTA transgenic mice (26) (Figure 1A) , which carry the tetracycline-dependent transcriptional activator under the control of the (Figure 2A,B) . A small number of SAβGal-positive cells were found also in control mice; we determined that 4-8% of epidermal cells underwent senescence in response to p14 ARF activation above this basal level ( Figure 2B and Figure S2 ).
We examined the expression of senescence-associated marker genes in mRNA extracted from whole skins. Dcr2 levels were mildly increased after two weeks of transgene induction, while Pai1 was not significantly induced ( Figure 2C) . Interestingly, the levels of the two products of the endogenous has been shown to execute p53-independent functions, but whether these pertain to senescence is unclear (30, 31) . We found that when an inducible transgenic shRNA against p53 (tet-shp53) (27) was co-expressed with the p14 
Senescent cells are retained in the epidermis
We next assessed whether, once formed, senescent cells are retained in the epidermis or are rapidly eliminated. We activated p14 S4 ). Epidermal thickness was increased in some mice, a potential result of the observed hyperproliferation; however this increase was limited in significance and was variable among mice and skin regions ( Figure S4 ).
The most striking change in the skin was a dramatic decrease in the numbers of developed hair follicles (HFs), and progressive hair loss (alopecia), which was noticeable 10 days after induction and pronounced by six weeks (Figure 5A,B) . The growth stage of hair follicles, anagen, is initiated by entry into the cell cycle of HF stem cells residing in the bulge region; this occurs synchronously in all HFs at 3 weeks of age (32) . We found that the transgenic p14 To directly test whether transgene re-silencing would allow hair growth, we activated p14 ARF for 6 weeks to induce more widespread alopecia, and then re-silenced the transgene for another 4 weeks; this did not result in hair re-growth ( Figure 6E ). These findings indicate that the majority of bulge cells attain a non-proliferative state that is not reversed after transgene silencing. The parameters determining the different outcomes of p53 activation remain largely unknown (28) . In the context of TPA-induced hyperplasia, despite the presence of p14 ARF -expressing cells, we did not detect increased senescence. There are several possible explanations for this interesting finding: TPA could affect keratinocytes in a manner preventing their senescence, increased epidermal cell turnover during hyperplasia could lead to the rapid elimination of transgene-expressing cells prior to their entry into senescence, or a rapid mechanism for directed senescent cell removal could be activated in these conditions, potentially mediated by TPA-induced inflammation (34) . Additional study is required to distinguish between these possibilities. Interestingly, we noted increased epidermal thickness in TPA- 
